Sanjay Vyas

President, Managing Director India & SBU Head for Clinical Logistics & Pharmacovigilence @parexel. An eternal optimist & passionate leader. Opinions are my own.

[Sanjay Vyas @MeSanjayvyas]

I believe that the world is on the cusp of transition to ensure that gender diversity becomes a way of life and does not remain just another initiative or thought. Shared some my thoughts…please read https://t.co/DxODkKXG0k

[Sanjay Vyas @MeSanjayvyas]

🔔As 2025 closes, we're excited for another year of accelerating the delivery of life-changing treatments.🎁To celebrate, Parexel is donating to Make-A-Wish Foundation International®️, a non-profit that grants wishes to children living with a critical illness.🎇 Happy holidays!

[Sanjay Vyas @MeSanjayvyas]

Excited to announce that Divya Murarka, Parexel India's Senior Director, will moderate a panel on medical writing at the 18th Annual ISCR Conference! Join us in Navi Mumbai, Jan 31-Feb 1, 2025. Let's connect and explore together!

[Sanjay Vyas @MeSanjayvyas]

Meet Iram Qayum: Leading with purpose at Parexel! Her strategic planning and global collaboration turn challenges into opportunities for innovation. Explore her journey: https://t.co/VpQi6HUUGI.

[Sanjay Vyas @MeSanjayvyas]

At Parexel, we're proud to champion women in leadership! Our programs have boosted women VPs from 33.5% to 45.6% in 10 years. Discover how you can grow with us. Learn more: https://t.co/yi0m9CjVRw

[Sanjay Vyas @MeSanjayvyas]

Check out the latest research from Lin Zhang, Jaime Smith, and Chao Wang on expanding the use of AI to expedite access to clinically relevant data in China:

https://t.co/kC8IodPVHf

[Sanjay Vyas @MeSanjayvyas]

India’s clinical research landscape presents both unique challenges and exciting opportunities for growth. In a conversation with Economic Times - ET Edge Insights,: https://t.co/6WZq9CGEu8

[Sanjay Vyas @MeSanjayvyas]

Parexel implemented a direct-to-patient application to recruit diverse patients and collect RWD. Read more in this article just published by ISPOR in the Value & Outcomes Spotlight. https://t.co/A4rlECuSAM

[Sanjay Vyas @MeSanjayvyas]

Parexel has released its 2023 ESG Report ─ part of Parexel’s annual commitment to disclose progress on sustainability priorities and underscoring our core values of putting Patients First and delivering With Heart™. Check out the report! 👇🌎
https://t.co/9hK2kPIMKk

[Sanjay Vyas @MeSanjayvyas]

Stephen Pyke recently joined Episode 2 of @ACRO's Good Clinical Podcast. They discussed the potential of AI in clinical research, delving into topics such as FDA's evidentiary standards for AI and methodological transparency in submissions. Access below! https://t.co/tLgoS13kXG

[Sanjay Vyas @MeSanjayvyas]

More than 80% of C-suite executives from healthcare and life sciences organizations see improved health equity as a top-10 goal for 2024. https://t.co/4NosJsRNib

[Sanjay Vyas @MeSanjayvyas]

In this interview, had an opportunity to speak to Asia Business Outlook magazine about how India's diversity and evolving infrastructure are transforming the clinical research landscape. Read it below! 👇 https://t.co/YyECxJjCHJ

[Sanjay Vyas @MeSanjayvyas]

Local and global industry stakeholders gathered recently in Mumbai for Parexel's annual India Symposium. This event sparks discussions around the future of clinical trials in India and how we can build on strategies for delivering new medicines to patients in need. 🩺

[Sanjay Vyas @MeSanjayvyas]

Parexel is once again a recipient of the CRO Leadership Award! Each year Clinical Leader evaluates CROs based on feedback from the sponsors who have worked with each CRO over the past 18 months. Thank you to our sponsors whose feedback contributed to our recognition!

[Sanjay Vyas @MeSanjayvyas]

At the Mint Digital Innovation Summit, Roopa Basrur discussed how AI is powering digital transformation across sectors in India. 💡 She highlighted the impact of AI in areas like workflow automation, data search and retrieval and medical writing. https://t.co/7ABa721wvL

[Sanjay Vyas @MeSanjayvyas]

In part 3 of this video interview with ACT, Stephen Pyke discusses the importance of collaboration and data sharing. Hear why he believes “fine tuning” is needed to advance AI applications and why collaboration will be key to fulfilling the promise of AI: https://t.co/AlUvwDwmWX

[Sanjay Vyas @MeSanjayvyas]

In Part 2 of his @Clin_Trials interview, Stephen Pyke discusses areas where we’ll likely see major advancements in our industry due to #AI, namely speed, quality and productivity in clinical research. Watch the full video here: https://t.co/1Pqk0C85vK

[Sanjay Vyas @MeSanjayvyas]

Jonathan Shough, Parexel's Chief Information Officer, discusses the importance of digital transformation and its effect on the clinical research industry with the Harvard Business Review. https://t.co/GNf5PHofsV

[Sanjay Vyas @MeSanjayvyas]

Parexel and Palantir, a leading builder of AI systems, announced a multi-year strategic partnership to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers: https://t.co/WC2yNLhIhW

[Sanjay Vyas @MeSanjayvyas]

In this article, i had an opportunity to weighs in on how the post-pandemic shift toward more decentralized clinical trial models has changes the way we approach clinical supply chain management and logistics. Read it here: https://t.co/agNQJ1kWO4

[Sanjay Vyas @MeSanjayvyas]

Congratulations to my colleague Deb Tatton on being recognized as a 2024 HBA Luminary for her nearly three-decades of leadership at Parexel! Looking forward to seeing photos from the ceremony on May 10! 📷 Check out the full list of honorees: https://t.co/ThzcUHp8OD